VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KROS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
KROSKeros Therapeutics, Inc.
$9.36$300M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKROSQuarterly Balance Sheet

Keros Therapeutics, Inc. (KROS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Keros Therapeutics, Inc. (KROS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

KROS Balance Sheet

Quarterly statement

KROS Balance Sheet

Keros Therapeutics, Inc. (KROS) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets287.63M266.88M290.68M315.43M719.31M732.81M759.51M588.89M552.05M432.71M463.13M347.29M304.44M334.31M362.22M285.77M245.88M222.36M231.22M251.44M
Cash & Short-Term Investments259.46M257.61M281.5M287.42M693.47M690.22M720.54M559.93M530.68M405.86M442.44M331.15M287.89M322.03M351.43M279.05M239.43M215.62M228.59M230.04M
Cash Only259.46M257.61M281.5M287.42M693.47M690.22M720.54M559.93M530.68M405.86M442.44M331.15M287.89M322.03M351.43M279.05M239.43M215.62M228.59M230.04M
Short-Term Investments00000000000000000000
Accounts Receivable22.25M2.76M2.96M6.37M5.57M17.74M19.37M4.46M1.92M1.34M1.78M1.09M898K964K1.15M841K146K146K167K18.2M
Days Sales Outstanding28.75-1.14K1.43K75.1692.955.0896.46387.443.84K1.57K639.8210.71K------42.24
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets5.92M6.52M1.03M2.4M2.65M2.52M2.94M1.48M1.39M582K616K1M319K376K515K276K745K466K251K210K
Total Non-Current Assets19.74M20.72M21.62M22.59M23.48M24.36M25.05M26.99M27.23M22.31M22.69M22.73M21.81M22M22.21M21.01M6.67M4.3M3.92M3.81M
Property, Plant & Equipment18.28M19.27M20.17M21.14M22.03M22.91M23.14M23.49M24.19M18.94M19.43M19.47M19.03M19.1M19.3M17.57M2.13M2.31M2.32M2.4M
Fixed Asset Turnover2.13x-0.02x0.02x0.63x0.79x9.06x0.13x0.02x0.00x0.00x0.01x0.00x------8.06x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments01.45M01.45M1.45M01.45M1.45M1.45M00000000000
Other Non-Current Assets1.46M01.45M001.45M463K2.06M1.59M3.37M3.26M3.26M2.79M2.9M2.92M3.44M4.55M1.99M1.6M1.41M
Total Assets307.37M287.6M312.29M338.02M742.78M757.16M784.56M615.89M579.27M455.02M485.82M370.02M326.25M356.31M384.44M306.78M252.55M226.66M235.14M255.25M
Asset Turnover0.13x-0.00x0.00x0.02x0.02x0.30x0.01x0.00x0.00x0.00x0.00x0.00x------0.08x
Asset Growth %-58.62%-62.02%-60.2%-45.12%28.23%66.4%61.49%66.44%77.56%27.71%26.37%20.62%29.18%57.2%63.49%20.19%9.82%-6.9%-8.76%-5.27%
Total Current Liabilities15.86M12.15M12.85M20.41M24.09M34.71M39.38M27.45M29.01M21.25M18.72M24.37M16.7M16.09M15.46M16.55M11.53M15.45M11.65M11.85M
Accounts Payable3.79M1.82M1.49M1.97M2.3M5.27M6.64M4.6M4.98M6.54M4.99M5.45M3.87M4.15M4.68M3.34M2.65M7.66M3.06M3.65M
Days Payables Outstanding--386.35490.48880.991.46K-1.33K1.69K---668.96------983.36
Short-Term Debt2.69M2.6M000000000000000000
Deferred Revenue (Current)0000155K925K3.31M0000000000000
Other Current Liabilities13.16M7.74M3.46M6.09M9.16M8.51M5.82M416K8.38M5.78M4.79M8.21M6.51M4.49M3.02M5.56M4.16M3.18M1.44M2.58M
Current Ratio18.14x21.96x22.62x15.45x29.86x21.11x19.29x21.45x19.03x20.37x24.74x14.25x18.23x20.77x23.43x17.27x21.33x14.39x19.85x21.23x
Quick Ratio18.14x21.96x22.62x15.45x29.86x21.11x19.29x21.45x19.03x20.37x24.74x14.25x18.23x20.77x23.43x17.27x21.33x14.39x19.85x21.23x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities12.41M13.13M13.81M14.47M15.11M15.72M16.31M16.88M17.43M12.86M13.15M13.44M13.7M13.95M13.99M12.81M000231K
Long-Term Debt12.41M13.13M13.81M00000000000000000
Capital Lease Obligations00014.47M15.11M15.72M16.31M16.88M17.43M12.86M13.15M13.44M13.7M13.95M13.99M12.81M000231K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities28.27M25.28M26.66M34.89M39.2M50.43M55.69M44.33M46.44M34.11M31.87M37.81M30.41M30.05M29.45M29.36M11.53M15.45M11.65M12.08M
Total Debt15.11M15.72M16.31M16.88M17.43M17.95M18.41M18.86M19.29M13.96M14.2M14.44M14.31M13.95M13.99M13.27M455K670K884K1.09M
Net Debt-244.35M-241.88M-265.19M-270.53M-676.04M-672.26M-702.13M-541.07M-511.4M-391.91M-428.24M-316.7M-273.58M-308.07M-337.44M-265.78M-238.97M-214.95M-227.7M-228.95M
Debt / Equity0.05x0.06x0.06x0.06x0.02x0.03x0.03x0.03x0.04x0.03x0.03x0.04x0.05x0.04x0.04x0.05x0.00x0.00x0.00x0.00x
Debt / EBITDA1.18x-----0.12x-------------
Net Debt / EBITDA-19.06x------4.61x-------------
Interest Coverage-------------------24185.00x-4941.00x
Total Equity279.1M262.32M285.63M303.13M703.58M706.73M728.87M571.55M532.84M420.92M453.95M332.21M295.84M326.26M354.98M277.42M241.03M211.21M223.49M243.17M
Equity Growth %-60.33%-62.88%-60.81%-46.96%32.04%67.9%60.56%72.04%80.11%29.01%27.88%19.75%22.74%54.47%58.83%14.08%10.32%-10.37%-10.02%-7.09%
Book Value per Share-13.2514.5511.1517.3217.4017.7714.1714.7611.6615.4211.039.9711.0212.5110.159.438.789.3110.38
Total Shareholders' Equity279.1M262.32M285.63M303.13M703.58M706.73M728.87M571.55M532.84M420.92M453.95M332.21M295.84M326.26M354.98M277.42M241.03M211.21M223.49M243.17M
Common Stock4K4K4K4K4K4K4K4K4K3K3K3K3K3K3K2K2K2K2K2K
Retained Earnings-520.03M-534.18M-505.47M-481.76M-458.3M-451.02M-420.33M-568.78M-522.75M-469.8M-424.54M-381.43M-341.18M-301.74M-264.24M-228.43M-198.72M-175.21M-147.94M-123.75M
Treasury Stock0-384.56M-384.56M-384.56M0000000000000000
Accumulated OCI00000000000000000000
Minority Interest00000000000000000000